SAWRABHYA KALAPURAKKAL: Open Payments
NPI 1639636699 · CORAL SPRINGS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,962 in 165 payments from 19 companies in 2025. Trend: 2023 $255 · 2024 $1,538 · 2025 $3,962
Food & beverage: $3,962
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 34 | $804 |
| Madrigal Pharmaceuticals | 14 | $594 |
| ABBVIE INC. | 29 | $507 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $373 |
| Ardelyx, Inc. | 15 | $322 |
| GENZYME CORPORATION | 7 | $245 |
| Lilly USA, LLC | 10 | $233 |
| Aimmune Therapeutics, Inc. | 11 | $214 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $206 |
| Phathom Pharmaceuticals, Inc. | 1 | $117 |
Products named: TREMFYA, REZDIFFRA, IBSRELA, DUPIXENT, ZENPEP, OMVOH, XIFAXAN, ENTYVIO.
Industry payments across FL — which companies pay providers there.
